Literature DB >> 9366273

N-dibenzylphospho-N'-3-(2,6-dichlorophenyl)propyl-guanidine is a bisubstrate-analog for creatine kinase.

K L Min1, J P Steghens, R Henry, A Doutheau, C Collombel.   

Abstract

We describe a new compound, N-dibenzylphospho-N'-3-(2,6-dichlorophenyl)-propylguanidine (DPPG), and our study of its interaction with cytosolic CK. To our knowledge, it is the most potent inhibitor known for CK: the Ki value versus ADP was 330 nM and 110 nM for CK-MM and BB respectively. In view of the inhibition pattern, Ki(app) dependencies on the second substrate, and very low Ki values, we conclude that DPPG binds to the active site as a bisubstrate-type analog. This bisubstrate analog confirms different mechanisms for CK-MM and BB: in spite of a more than 80% similarity in amino-acid sequences, both isoenzymes are random at pH 8.6 but CK-BB has an ordered mechanism at pH 6.6.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366273     DOI: 10.1016/s0167-4838(97)00088-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  1 in total

1.  S-alkylated homocysteine derivatives: new inhibitors of human betaine-homocysteine S-methyltransferase.

Authors:  Jiri Jiracek; Michaela Collinsova; Ivan Rosenberg; Milos Budesinsky; Eva Protivinska; Hana Netusilova; Timothy A Garrow
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.